Skip to content

INNOVATION1 BIOTECH INC.: 10-Q filed 2019-07-18

What INNOVATION1 BIOTECH INC. reported in its quarterly report filed 2019-07-18 (fiscal Q3 2019): 31 published measures, 87 facts as tagged in accession 0001477932-19-004162.

This filing

Form
10-Q (quarterly report)
Filed
2019-07-18
Fiscal period
fiscal Q3 2019
Accession
0001477932-19-004162 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INNOVATION1 BIOTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-05-31331,475USD
At 2018-08-31862,743USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-05-3179,372USD
At 2019-02-2887,840USD
At 2018-11-2871,892USD
At 2018-08-31175,875USD
At 2018-05-31-249,951USD
At 2017-11-28-86,316USD
At 2017-08-31-13,276USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-05-3113,935USD
At 2018-08-31774,468USD
At 2018-05-317,493USD
At 2017-08-3125USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-22,457USD92
2018-09-01 to 2019-05-31-100,712USD273
2018-11-29 to 2019-02-2813,153USD92
2018-09-01 to 2018-11-28-91,408USD89
2018-06-01 to 2018-08-31-811,889USD92
2018-03-01 to 2018-05-31-18,970USD92
2017-11-29 to 2018-05-31-163,635USD184
2017-09-01 to 2018-05-31-163,635USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-757,555USD273
2017-09-01 to 2018-05-31-191,037USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-2,978USD273
2017-09-01 to 2018-05-31-2,467USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-03-01 to 2019-05-3117,846USD92
2018-09-01 to 2019-05-3181,233USD273
2018-03-01 to 2018-05-315,043USD92
2017-09-01 to 2018-05-3115,329USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-09-01 to 2018-05-31200,972USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-2,978USD273
2017-09-01 to 2018-05-31-2,467USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-05-31-1,131,629USD
At 2018-08-31-993,192USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-05-313,951USD
At 2018-08-311,937USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-09-01 to 2019-05-313,210USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-143,258USD92
2018-09-01 to 2019-05-31-489,141USD273
2018-03-01 to 2018-05-31-18,847USD92
2017-09-01 to 2018-05-31-163,283USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-05-31324,724USD
At 2018-08-31858,006USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-03-01 to 2019-05-31247USD92
2018-09-01 to 2019-05-31370USD273
2018-03-01 to 2018-05-31123USD92
2017-09-01 to 2018-05-31352USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-05-31252,103USD
At 2018-08-31686,868USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-05-313,722USD
At 2018-08-31428USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-03-01 to 2019-05-31154,590USD92
2018-09-01 to 2019-05-31505,930USD273
2018-03-01 to 2018-05-3116,864USD92
2017-09-01 to 2018-05-31152,355USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-05-31277,067USD
At 2018-08-3153,110USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-03-01 to 2019-05-3111,332USD92
2018-09-01 to 2019-05-3116,789USD273
2018-03-01 to 2018-05-31-1,983USD92
2017-09-01 to 2018-05-31-10,928USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-03-01 to 2019-05-316,514USD92
2018-09-01 to 2019-05-3164,444USD273
2018-03-01 to 2018-05-317,026USD92
2017-09-01 to 2018-05-3126,257USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-05-31133,900,130shares
At 2018-08-31132,637,500shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-05-31908,520USD
At 2018-08-31867,949USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-05-311,493USD
At 2018-08-31529USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-05-31845USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-03-01 to 2019-05-3139,838USD92
2018-09-01 to 2019-05-31149,085USD273
2018-03-01 to 2018-05-315,993USD92
2017-09-01 to 2018-05-3145,235USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-09-01 to 2019-05-31964USD273
2017-09-01 to 2018-05-31324USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-03-01 to 2019-05-31-120,801USD92
2018-09-01 to 2019-05-31-388,429USD273
2018-03-01 to 2018-05-31123USD92
2017-09-01 to 2018-05-31352USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-09-01 to 2018-05-31160,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-3,294USD273
2017-09-01 to 2018-05-31-428USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-09-01 to 2019-05-31-223,957USD273
2017-09-01 to 2018-05-31-38,476USD273

Inspect the source

Entity
INNOVATION1 BIOTECH INC. / CIK 0001629205
Captured
2026-09-21T17:21:04.610Z
SEC response SHA-256
c5f3acfa863971b33b185130c620366a2f45cfd805cf4850d8be9be21b48d8fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001629205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))